X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (11) 11
cancer (10) 10
immunology (9) 9
immunotherapy (9) 9
peptides (9) 9
beer (8) 8
biochemistry (8) 8
chemistry (8) 8
compositions thereof (8) 8
culture media (8) 8
enzymology (8) 8
metallurgy (8) 8
microbiology (8) 8
microorganisms or enzymes (8) 8
mutation or genetic engineering (8) 8
organic chemistry (8) 8
propagating, preserving or maintaining microorganisms (8) 8
spirits (8) 8
vinegar (8) 8
wine (8) 8
animals (7) 7
chimeric antigen receptor (7) 7
female (7) 7
mice (6) 6
oncology (6) 6
t cells (6) 6
t-lymphocytes - immunology (6) 6
ovarian cancer (5) 5
cell line, tumor (4) 4
expression (4) 4
mice, scid (4) 4
neoplasms - therapy (4) 4
ovarian neoplasms - immunology (4) 4
ovarian neoplasms - pathology (4) 4
tumors (4) 4
abridged index medicus (3) 3
antibody (3) 3
antigens (3) 3
antitumor-activity (3) 3
apoptosis (3) 3
breast-cancer (3) 3
carcinoma, ovarian epithelial (3) 3
care and treatment (3) 3
cytotoxicity (3) 3
lymphocytes (3) 3
lymphocytes t (3) 3
medical research (3) 3
monocytes (3) 3
neoplasms - immunology (3) 3
original (3) 3
ovarian neoplasms - therapy (3) 3
prognosis (3) 3
recombinant fusion proteins - immunology (3) 3
research (3) 3
survival (3) 3
t-cells (3) 3
xenograft model antitumor assays (3) 3
αvβ6 (3) 3
animal models (2) 2
antigens, neoplasm - immunology (2) 2
apoptosis - drug effects (2) 2
b7-h1 (2) 2
b7-h1 antigen - genetics (2) 2
b7-h1 antigen - metabolism (2) 2
breast cancer (2) 2
cancer research (2) 2
carboplatin - administration & dosage (2) 2
carcinoma (2) 2
cells (2) 2
cytokine release (2) 2
drug therapy (2) 2
factor-alpha (2) 2
flow cytometry (2) 2
gene expression (2) 2
gene expression regulation, neoplastic (2) 2
growth-factor receptor (2) 2
health aspects (2) 2
immunosuppression (2) 2
immunotherapy - methods (2) 2
immunotherapy, adoptive (2) 2
immunotherapy, adoptive - methods (2) 2
in-vivo (2) 2
inhibition (2) 2
integrins - immunology (2) 2
lymphocyte activation (2) 2
medical prognosis (2) 2
medicine & public health (2) 2
neoplasms, glandular and epithelial - therapy (2) 2
original article (2) 2
ovarian neoplasms - genetics (2) 2
pd-1 (2) 2
pd-1 protein (2) 2
pd-l1 protein (2) 2
proliferation (2) 2
receptors, antigen, t-cell - genetics (2) 2
receptors, antigen, t-cell - immunology (2) 2
recombinant fusion proteins - genetics (2) 2
safety (2) 2
solid tumor (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2017, Volume 23, Issue 13, pp. 3453 - 3460
Journal Article
Molecular Therapy, ISSN 1525-0016, 01/2017, Volume 25, Issue 1, pp. 259 - 273
Journal Article
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 05/2019, Volume 10, p. 1149
Antibody-derived chimeric antigen receptor (CAR) T cell therapy has achieved gratifying breakthrough in hematologic malignancies but has shown limited success... 
triple-negative breast cancer | MUC1 | MUC28z CAR T cells | TAB004 | immunotherapy | IN-VIVO | GLYCOFORM | ANTIBODY | GLYCOSYLATION | IMMUNOLOGY | EXPRESSION | PD-1 | Care and treatment | Usage | Immunotherapy | Breast cancer | Genetic aspects | Research | T cells | Gene expression
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 11/2018, Volume 67, Issue 11, pp. 1753 - 1765
Journal Article
Cancers, ISSN 2072-6694, 05/2019, Volume 11, Issue 5, p. 674
Despite the unprecedented clinical success of chimeric antigen receptors (CAR) T-cells against haematological malignancy, solid tumors impose a far greater... 
T-cell | CAR-T | αvβ6 | immunotherapy | solid tumor | cancer | chimeric antigen receptor | homing | integrin | chemokine receptor
Journal Article
Advanced Healthcare Materials, ISSN 2192-2640, 06/2015, Volume 4, Issue 8, pp. 1180 - 1189
Journal Article
OncoImmunology, ISSN 2162-4011, 12/2017, Volume 6, Issue 12, pp. e1363137 - e1363137
Mesothelioma is an incurable cancer for which effective therapies are required. Aberrant MET expression is prevalent in mesothelioma, although targeting using... 
chimeric antigen receptor | cancer | mesothelioma | NK1 | MET | Immunotherapy | FACTOR SCATTER FACTOR | HEPATOCYTE GROWTH-FACTOR | PROLIFERATION | IMMUNOLOGY | IDENTIFICATION | FACTOR/SCATTER FACTOR | CHECKPOINT BLOCKADE | CHIMERIC ANTIGEN RECEPTORS | ONCOLOGY | C-MET | HEPARAN-SULFATE PROTEOGLYCANS | BINDING
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. 3046 - 3046
Conference Proceeding
JOURNAL OF IMMUNOLOGY, ISSN 0022-1767, 12/2014, Volume 193, Issue 11, pp. 5557 - 5566
Adoptive immunotherapy using gamma delta T cells harnesses their natural role in tumor immunosurveillance. The efficacy of this approach is enhanced by... 
ZOLEDRONIC ACID | GAMMA-DELTA | BISPHOSPHONATE | INHIBITION | IN-VIVO | TUMOR-CELLS | RECURRENCE | IMMUNOLOGY | ANTITUMOR-ACTIVITY | EX-VIVO | CYTOTOXICITY
Journal Article
Molecular Therapy, ISSN 1525-0016, 10/2017, Volume 25, Issue 10, p. 2427
(Molecular Therapy 25, 259–273; January 4, 2017) The authors regret that King's Health Partners Confidence in Concept was inadvertently omitted as a funding... 
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2013, Volume 1, Issue S1
Journal Article
by Schmidt, Manfred and Verhoeyen, Els and Gobbo, Emilie and Divers, Dominique and Oudrhiri, Noufissa and Griscelli, Frank and Bennaceur-Griscelli, Annelise and Klatzmann, David and Anguela, Xavier M and Sharma, Rajiv and Sharma, Rajiv and Li, Hojun and Li, Hojun and Haurigot, Virginia and Haurigot, Virginia and Haurigot, Virginia and Bhagwat, Anand and Bhagwat, Anand and Davidson, Robert and Davidson, Robert and Zhou, Shangzhen and Zhou, Shangzhen and Zhou, Shangzhen and Doyon, Yannick and Gregory, Philip D and Gregory, Philip D and Gregory, Philip D and Holmes, Michael C and Holmes, Michael C and Holmes, Michael C and High, Katherine A and Carbonaro, Denise and Shaw, Kit and Jin, Xiangyang and Geiger, Sabine and Mishra, Suparna and Cooper, Aaron and DeOliveira, Satiro and Sokolic, Rob and Candotti, Fabio and Carmo, Marlene and Arumugam, Paritha and Alonso-Ferrero, Maria and Schambach, Axel and Schambach, Axel and Baum, Christopher and Baum, Christopher and Baum, Christopher and Risma, Kimberly and Malik, Punam and Jordan, Michael and Rivat, Christine and Booth, Claire and Thrasher, Adrian and Whilding, Lynsey and Archibald, Kyra and Oberg, Daniel and Golan, Talia and Hubert, Ayala and Shemi, Amotz and Khvalevsky, Elina Zorde and Gabai-Malka, Racheli and Focht, Gili and Brunschwig, Zivia and Raskin, Stephen and Goldberg, Nahum and Ben-David, Eli and Peretz, Tamar and Eliakim, Rami and Dankur, Alan and Galun and Rachmur, Itzik and Domb, Avi and Kopelman, Yael and Hantz, Yael and Lahav, Mor and Arbel-Alon, Sagit and Dickson, George and Barkats, Martine and Daboussi, Fayza and Silva, Georges and Cedrone, Frederic and Epinat, Jean Charles and Juillerat, Alexandre and Valton, Julien and Montini, Eugenio and Biffi, Alessandra and Biffi, Alessandra and Calabria, Andrea and Calabria, Andrea and Biasco, Luca and Biasco, Luca and Cesani, Martina and Cesani, Martina and Benedicenti, Fabrizio and Benedicenti, Fabrizio and Plati, Tiziana and Leo, Simone and Zanetti, Gianluigi and Aiuti, Alessandro and ...
Human Gene Therapy, ISSN 1043-0342, 10/2012, Volume 23, Issue 10, pp. A1 - A173
Journal Article